Drug‐Free Thrombolysis Mediated by Physically Activated Micro/Nanoparticles
Open Access
- 21 January 2026
- journal article
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (34)
Abstract
Thrombus‐associated disorders rank among the world's leading causes of death, with ischemic heart disease and stroke as the main contributors. Systemic administration of fibrinolytic drugs remains the gold standard treatment for thrombotic diseases, but suffers from severe adverse effects and low recanalization rates. For over three decades, nanomedicine has attempted to overcome these limitations through drug vectorization; however, no nanoparticle‐based fibrinolytic formulation has reached clinical approval so far. In this context, physically activated micro/nanoparticles have emerged as promising alternatives. Remotely triggered by light, ultrasound, or magnetic fields, these systems can destabilize thrombi through hyperthermia, mechanical disruption, or chemical reactions, acting on multiple thrombus components beyond fibrin. Nonetheless, since these emergent thrombolytic therapies are often combined with pharmaceutical drugs, including fibrinolytics, their intrinsic thrombolytic performance remains difficult to assess. For the first time, this review focuses exclusively on drug‐free, stimulus‐responsive micro/nanosystems for thrombolysis. Its originality lies in an analytical framework that classifies studies by thrombolytic effect (thermal, mechanical, chemical, or combinations) rather than by particle composition, aiming at clarifying their mechanisms of action, which clot components are affected, and how effective they are in promoting thrombolysis. Finally, translational challenges, including safety and device considerations, are discussed to guide future non‐pharmaceutical thrombolytic therapies.Keywords
Funding Information
- Agence Nationale de la Recherche
This publication has 138 references indexed in Scilit:
- Sonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence ImagingAdvanced Materials, 2025
- Phosphatidylcholine Liposome Accelerated Platinum Nanomachines (PLANEs) With Enhanced Penetration Capability for Thrombus MechanotherapyAdvanced Materials, 2025
- Untethered & Stiffness‐Tunable Ferromagnetic Liquid Robots for Cleaning Thrombus in Complex Blood VesselsAdvanced Materials, 2024
- Ultrasound‐Assisted Photothermal Therapy (ULTRA‐PTT) for the Treatment of Deep‐Seated TumorsAdvanced Optical Materials, 2024
- Plasma‐Derived Nanoclusters for Site‐Specific Multimodality Photo/Magnetic Thrombus TheranosticsAdvanced Healthcare Materials, 2023
- A Biomimicking and Multiarm Self‐Indicating Nanoassembly for Site‐Specific Photothermal‐Potentiated Thrombolysis Assessed in Microfluidic and In Vivo ModelsAdvanced Healthcare Materials, 2023
- Activated Platelet‐Targeted IR780 Immunoliposomes for Photothermal ThrombolysisAdvanced Functional Materials, 2022
- Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C‐Shaped Magnetic Actuation System In VivoAdvanced Materials, 2021
- Surface Wettability of Nanoparticle Modulated SonothrombolysisAdvanced Materials, 2021
- Metal–Organic‐Framework‐Derived Carbon Nanostructures for Site‐Specific Dual‐Modality Photothermal/Photodynamic Thrombus TherapyAdvanced Science, 2019